-
For Consumers
-
What's New at FDA in Hepatitis
This page contains an archive of information distributed through the FDA Hepatitis e-mail list, designed to provide a source for FDA information on a variety of topics related to hepatitis, including:
- product approvals
- significant labeling changes
- safety warnings
- notices of upcoming public meetings
- proposed regulatory guidances, and opportunity to comment
Sign up to receive Hepatitis email updates
-
2009
- New class safety labeling updates for alpha interferon products
- New Rules for Expanded Access to Investigational Drugs for Treatment Use and Charging for Investigational Drugs
- Dose adjustments of PegIntron and Rebetol for certain patients with chronic hepatitis C
- Important information about Hydroxycut dietary supplement products
- Approval of new oral solution of Tyzeka for treatment of chronic hepatitis B (HBV)
-
-
-